Were they ever listed as an outcome?
"
Feasibility analysis will include: the number of
young people eligible, approached and consented to the trial; attrition rate and
treatment adherence; questionnaire and accelerometer completion rates."
"
Quantitative data will include: the number of children who were eligible, approached,
consented and retained in the study; the completeness of questionnaire data at
baseline assessment and follow:up; the percentage of children providing usable
accelerometer data;"
"
We will calculate the proportion of children who wear the accelerometer and provide
usable data. We will assume periods of sixty minutes or more with zero readings as
“non:wear” time. Participant’s data will be included if they provide two or more
weekdays of data with at least 500 minutes of data between 6am and 11pm."
"
In addition to questionnaire measures,
participants in both trial arms will be asked to
wear an accelerometer (GT3X+) to measure physical activity for seven days within
one month of randomisation and at 3 and 6 months follow:up. Accelerometers will be
posted to participants with instructions. Participants will be asked to complete a log
of wear time (time worn and time taken off). Accelerometers are small, match box
sized devices that measure physical activity. They have been shown to provide
reliable indicators of physical activity among children and adults
23
. The accelerometer data will be processed to identify mean minutes of sedentary, light
and moderate to vigorous intensity physical activity per day using established
accelerometer cut off points and protocols
16 24
. The mean accelerometer counts per minute, which provides an indication of the volume of physical activity in which the participant engages, will also be calculated using established methods."
"We will interview children and adolescents and their parents about their use of the accelerometer, whether it is an acceptable device to wear and whether there are particular issues we need to consider in this patient group for the full trial."